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Background: Basement matrices such as Matrigel™ and Geltrex™ are used in a variety of cell culture assays of
anchorage-dependent differentiation including endothelial cell tube formation assays. The volumes of matrix
recommended for these assays (approximately 150 μl/cm2) are costly, limit working distances for microscopy, and require
cell detachment for subsequent molecular analysis. Here we describe the development and validation of a thin-layer
angiogenesis (TLA) assay for assessing the angiogenic potential of endothelial cells that overcomes these limitations.
Results: Geltrex™ basement matrix at 5 μl/cm2 in 24-well (10 μl) or 96-well (2 μl) plates supports endothelial cell
differentiation into tube-like structures in a comparable manner to the standard larger volumes of matrix. Since working
distances are reduced, high-resolution single cell microscopy, including DIC and confocal imaging, can be used readily.
Using MitoTracker dye we now demonstrate, for the first time, live mitochondrial dynamics and visualise the
3-dimensional network of mitochondria present in differentiated endothelial cells. Using a standard commercial
total RNA extraction kit (Qiagen) we also show direct RNA extraction and RT-qPCR from differentiated endothelial
cells without the need to initially detach cells from their supporting matrix.
Conclusions: We present here a new thin-layer assay (TLA) for measuring the anchorage-dependent differentiation
of endothelial cells into tube-like structures which retains all the characteristics of the traditional approach but with
the added benefit of a greatly lowered cost and better compatibility with other techniques, including RT-qPCR and
high-resolution microscopy.
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Secreted extracellular matrix proteins, purified from the
Engelbreth-Holm-Swarm (EHS) tumour, such as Matrigel™
and Geltrex™, are widely used in a variety of cell culture ap-
plications [1-4], including the support of primary cell
propagation, and anchorage-dependent cell differentiation.
These cell differentiation assays include the morphogenesis
of endothelial cells (EC) into tube-like structures (tube-for-
mation assay) for the study of in vitro angiogenesis [3,5,6],
and the differentiation of neural cells in neurite outgrowth
assays [1].* Correspondence: dbishopbailey@rvc.ac.uk
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unless otherwise stated.The most common assay employed using basement
matrix is the EC tube formation assay, thought to represent
the differentiation stage of angiogenesis and often being ap-
plied as a first-pass screening assay of compounds with po-
tential pro- or anti-angiogenic properties (reviewed in
Staton et al., 2009 [7]). To study cell differentiation, a rela-
tively large volume of matrix is usually indicated with
recommendations and common usage of matrix in the
order of 50-200 μl/cm2, depending upon the assay to be
employed. As well as increasing the general cost associated
with performing these assays this volume of matrix also
precludes the use of experimental techniques such as high-
resolution/single cell microscopy and requires further cell
manipulation (e.g. dispase digestion) [8] in order to extract
mRNA for subsequent gene expression analysis. In anl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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layer angiogenesis assay (TLA) that would retain the ability
to act as an anchoring and differentiating platform, but
could also be used for high definition single cell imaging.
Here, we show that spreading low volumes of Geltrex™
basement membrane thinly onto glass or tissue culture
plastic enables the use of high-resolution imaging and dir-
ect RNA extraction from endothelial cells that are actively
engaged in the tube-forming process. This simple assay
generates comparable data to those derived from large
volume matrix assays, and has a far greater utility in terms
of imaging and transcriptional analysis accompanied by a
25–30 fold reduction in relative cost.
Results
The human endothelial cell line (EA.hy926) and primary
human umbilical vein endothelial cells (HUVEC) undergo
differentiation on a thin layer matrix
10 μl of growth factor-reduced Geltrex™ basement matrix
was spread evenly onto glass (13 mm coverslip) using a
sterile syringe insert. HUVEC or EA.hy926 formed tube-
like structures under non-stimulated conditions (vehicle
alone; 0.01% DMSO) and the number of tubes formed was
significantly increased in response to the distinct angiogen-
esis inducers vascular endothelial growth factor (VEGF;
25 ng/ml) and GW0742 (1 μM), a selective PPARβ/δ agon-
ist [3,6] (Figure 1). Similar results were obtained when
Geltrex™ matrix was spread directly onto tissue culture
plastic with VEGF-stimulated HUVEC showing a clear pro-
angiogenic response (Figure 2).
An advantage of the traditional angiogenesis assay is
scalability, with many research groups performing the
assay in a 96-well plate format using 50 μl/well of base-
ment matrix [6,9-11]. To determine if this higher through-
put can be achieved with the TLA assay, HUVEC (25,000
cells/cm2) were seeded on 2 μl of Geltrex™ basement
matrix in the presence of VEGF (25 ng/ml; 16 h) or
GW0742 (100 nM; 16 h). These experiments showed
that responses to VEGF and GW0742 using the TLA in
96-well plate format (Figure 3) were identical to those
measured using the coverslip TLA approach (Figure 1).
A common goal for those routinely using the basement
matrix assay for assessing angiogenic potential is the use
of automated quantification systems. The use of an
automated quantification system (ImageJ Angiogenesis
Analyzer) provides qualitatively but not always quanti-
tatively identical data to manual counting (Figure 4;
Additional file 1: Table S1).
The TLA approach is qualitatively similar to the
traditional thick layer approach
To make a direct comparison of the TLA approach with
the traditional thick layer, HUVEC were stimulated
to undergo tubulogenesis in the presence or absence ofVEGF (25 ng/ml) on either 2 μl/well or 50 μl/well of
Geltrex™ in a 96-well format. VEGF induced a similar
pro-angiogenic effect on HUVEC whether on a standard
thick or TLA basement matrix (Figure 5; Additional
files 2: Movie S1A and S1B).
Differential interference contrast (DIC) and confocal
microscopy of differentiated endothelial cells
Unlike cell monolayers, the traditional tube formation
assay with its large matrix volume has greatly reduced
microscopic working distances, making single cell ana-
lysis highly challenging. Using HUVEC stimulated with
VEGF (25 ng/ml; 16 h) in 35 mm glass-bottom plates
coated with 10 μl of Geltrex™, differential interference
contrast (DIC) images were acquired using a Zeiss Axiovert
135 microscope (×20 objective). As shown in Figure 6A the
TLA is clearly compatible with use of this high contrast
technique.
As proof-of-principle for live single cell and confocal
imaging we chose the well-established mitochondrial-
specific dye MitoTracker [12]. VEGF-stimulated HUVEC
(25 ng/ml; 16 h) were incubated for 40 min with Mito-
Tracker green (200nM). Live mitochondrial dynamics
(over 10 min; ×63 objective) were recorded within the
tube-like structures (Figure 6B and Additional file 3:
Movie S2). In addition to single cell-live imaging, the
3D mitochondrial network in differentiated endothelial
cells was reconstructed following z-stack deconvolution
(×40 objective) using a Leica SP5 confocal microscope
(Figure 6C and Additional file 4: Movie S3).
To demonstrate confocal imaging of fixed cells, HUVEC
differentiated using the TLA approach in chamber slides
(VEGF 25 ng/ml; 16 h) were fixed with 4% PFA and stained
for the common endothelial cell marker CD31 (PECAM)
(Figure 7 and Additional file 5: Movie S4).
Direct RNA extraction from HUVEC in the TLA assay for
use in RT-qPCR
Total RNA was extracted from HUVEC differentiated into
tubes using the TLA assay following exposure to VEGF
(25 ng/ml) without prior cell isolation according to the
manufacturer’s recommended protocol (Qiagen Total
RNA Extraction kit). Subsequent standard RT-qPCR ana-
lysis readily detected GAPDH and COX-2 expression (pre-
viously shown to increase in HUVEC in response to
VEGF treatment [6]). COX-2 expression in the TLA was
not significantly induced relative to GAPDH at 16 h
in VEGF stimulated tube-forming HUVEC (Figure 8 and
Additional file 6: Figure S2).
Discussion
The use of a basement matrix in the study of anchorage-
dependent differentiation is common place in many re-
search laboratories, with the endothelial cell tube formation
Figure 1 Human endothelial cells readily differentiate on thin layers of basement matrix spread on glass. (A) Representative images of
EA.hy926 and HUVEC forming tube-like structures after 24 and 16 hours, respectively, when plated onto 10 μl/2 cm2 of basement matrix in the
presence of VEGF (25 ng/ml) or GW0742 (1 μM). Images were acquired using Leica DMIRB microscope (x10 objective). Scale bar = 200 μm.
(B) Quantification of tubes formed by HUVEC at 16 hours in the presence of VEGF, GW0742 or DMSO control. Data represent mean (± S.E.M)
number of branches/field from n = 5 separate donors. **p < 0.01 vs. DMSO control as determined by repeated measures ANOVA followed by
Dunnett’s post analysis.
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of angiogenesis. The smallest volume of matrix used in this
assay to date is 15 μl/cm2 (30 μl per well of a 24-well plate)
[13] which is more cost effective than the recommended
volume of 50 μl/cm2 (100 μl per well of a 24-well plate) but
created a meniscus that promoted cell pooling [14]. In the-
ory, if the matrix layer becomes thin enough, significant
meniscus formation and subsequent cell pooling would be
overcome. Here, we demonstrate that the use of as little as
5 μl/cm2 (10 μl per well of a 24-well plate) is sufficient to
support the anchorage-dependent differentiation of endo-
thelial cells into tube-like structures without meniscus
formation and cell pooling. Using this thin layer approach
we demonstrate that the assay can be reproducibly per-
formed on glass or on plastic and that quantification of
tube-forming capacity shows the expected pro-angiogenic
responses to VEGF and the PPARβ/δ agonist GW0742
(Figures 1, 2, 3 and 5), consistent with published data from
our and other laboratories using a traditional matrix vol-
ume [3,6,15,16] and re-confirmed in side-by-side compari-
sons in this paper (Figure 5). Moreover, the TLA method
may provide a platform for more stable tube formation with
less network breakdown (Additional file 2: Movie S1). The
reason for this is not clear but may represent a further po-
tential advantage over the traditional thick layer approach.
A common problem with the standard assay is its
compatibility with automated analysis systems due toloss of focus, predominantly as a consequence of menis-
cus formation. With the TLA method reducing meniscus
formation we sought to identify if automated analysis using
the ImageJ Angiogenesis Analyzer freeware was compatible
with this thin layer approach. Automated analysis was
qualitatively (if not always quantifiably) similar to manual
counting (Figure 4), and can therefore (with this caveat) be
readily applied to the TLA method.
An additional benefit of using the TLA assay in a
24-well format is the ability to directly extract mRNA
from the tube-forming cells for gene expression analysis.
Traditionally, due to the large volume of gel present this
has been achieved by isolating the cells from the matrix
(e.g. by dispase digestion) which requires subjecting the
cells to additional chemical treatment and centrifugation
[8,17]. Accordingly, most studies investigate gene expres-
sion in endothelial cell monolayers and correlate the results
with outcomes from the functional tube formation assay
[3,18,19]. With the highly reduced gel volume, the TLA
approach presented here negates the need for cell detach-
ment from the matrix, thus allowing direct extraction of
RNA from cells which are undergoing or have completed
tubulogenesis. This modification therefore makes the
molecular analysis less time-consuming as well as circum-
venting the difficulties associated with extrapolating
between data derived from cell monolayers versus differen-
tiating endothelial cells. The ability to increase throughput
Figure 2 Human endothelial cells readily differentiate on thin layers of basement matrix spread on tissue culture plastic. (A) Representative
images of HUVEC forming tube-like structures after 16 hours when plated onto 10 μl/2 cm2 of basement matrix in the presence of VEGF (25 ng/ml) or
medium only control. Images were acquired using Leica DMIRB microscope (x10 objective). Scale bar = 200 μm. (B) Quantification of branches formed
by HUVEC at 16 hours in the presence of VEGF, or medium control. Data represent mean (± S.E.M) number of branches/field from n = 4 separate
donors. *p < 0.05 vs. medium control as determined by paired Student’s t-test.
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desirable to screen the effects of a number of different
compounds. In this respect we show that the TLA method-
ology can be used in a higher throughput format in 96-well
plates using 2 μl of matrix/well (Figure 3).Figure 3 The thin-layer angiogenesis assay (TLA) can be performed in
Representative images showing HUVEC (25,000 cells/cm2) forming tube-like
with more tubes forming in the presence of VEGF (25 ng/ml) or GW0742 (1
objective). Scale bar =200 μm. (B) Mean number of branches (± S.E.M)/field
(100nM) or DMSO control. *p < 0.05 vs. DMSO control as determined by re
separate donors ran in sextuplet.The ability to obtain high-resolution images from a
convenient low-cost in vitro assay is highly desirable.
We show here that one of the advantages of the TLA
assay with its greatly reduced working distances is the
use of high-resolution microscopy, including DIC anda 96-well plate format using 2 μl of basement matrix. (A)
structures after 16 hours when plated onto 2 μl of basement matrix
00nM). Images were acquired using Leica DMIRB microscope (x10
formed at 16 hours in the presence of VEGF (25 ng/ml), GW0742
peated measures ANOVA followed by Dunnett’s post analysis, n = 6
Figure 4 Comparison of manual versus automated quantitation
of angiogenic parameters. A comparison of (A) average number of
branches/field and (B) average number of junctions/field obtained
from the 24-well data acquired from the HUVEC TLA experiments
reported in Figure 1 when quantified manually or with the use of
the angiogenesis macro for ImageJ. n = 5 independent donors.
*p < 0.05 **p < 0.01 ***p < 0.001 vs control as determined by
one-way ANOVA followed by Dunnett’s post-analysis test.
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ing cellular and intracellular processes, demonstrated
here by the immunofluorescent staining of CD31. More-
over, with the growing interest in the role played by cell
organelles such as the mitochondria in the angiogenicFigure 5 Direct comparison of the thin layer angiogenesis (TLA) assay
number of branches/field (manual count) formed by HUVEC (25,000 cells/c
thick layer assay (A) and the TLA assay (B). **p < 0.01 vs. control as determprocess [20,21], we have successfully monitored the
mitochondrial network and dynamics during endothelial
cell tubulogenesis. To our knowledge we are the first to
show such high-resolution images of live mitochondria
within developing tubules.
Conclusions
The use of a basement matrix in the study of anchorage-
dependent differentiation is common place in many re-
search laboratories, with the endothelial cell tube formation
assay being the most widely used in vitro assay for in-
vestigating the angiogenic functions of endothelial cells.
Current recommended matrix volumes make this an ex-
pensive assay, preclude the use of more advanced imaging
techniques, and limit the ease with which molecular data
can be acquired. We have described a modified method
for this basement matrix assay which provides all the neces-
sary support required for differentiation, generating results
which are similar to those obtained using the traditional ap-
proach. In conclusion, our thin layer angiogenesis assay
makes for the ideal first-pass angiogenesis screening assay
with a substantially lowered cost (25–30 fold) compared to
commonly used similar in vitro angiogenesis assays, whilst
at the same time maximising high through put testing, and
gives the user greatly reduced working distances that allows,
for the first time with this assay, single cell, high resolution
imaging of actively differentiating cells.
Methods
Cell culture
EA.Hy926 cells were cultured in Dulbecco’s Modified Ea-
gles Medium (DMEM) (Sigma Aldrich, Gillingham, UK)
supplemented with 10% foetal bovine serum (FBS) and
1% penicillin/streptomycin (Pen/Strep) at 37°C, 5% CO2.
Unless stated, experiments were carried out in serum-free
DMEM (1% pen/strep). Human Umbilical Vein Endothe-
lial Cells (HUVEC) were isolated from donated cords as
previously described [6] and cultured under standardwith standard thick layer assay. Comparison of the average
m2) in the presence or absence of VEGF (25 ng/ml) in the standard
ined by student’s paired t-test.
Figure 6 High contrast images of differentiated HUVEC in the
TLA assay by Differential Interference Contrast (DIC) and
confocal fluorescence microscopy. HUVEC stimulated to form
tube-like structures with 25 ng/ml VEGF on a 35 mm glass-bottom
dish covered with 10 μl matrix is compatible with DIC (x20 objective)
(A) and confocal microscopy (x63 objective); Scale bar = 25 μm
(B). Mitochondria (green) were stained using MitoTraker green
(200nM). For 3D imaging (C) of the mitochondrial network, z-stacks
were obtained at x40 magnification and re-constructed using
Volocity software.
Figure 8 Direct RNA extraction and RT-qPCR analysis of HUVEC
immediately after the TLA assay. Fold relative COX-2 mRNA to
GAPDH expression in VEGF-treated HUVEC undergoing differentiation
in 24-well plates in the TLA assay. RNA was directly extracted from
the cells and targets measured by Taqman RT-qPCR; n = 4 separate
experiments.
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20 μg/ml endothelial cell growth factor (ECGF) and 20%
FBS. Cells were used at passage 2. Unless stated, HUVEC
experiments were carried out in M199 (1% FBS; 1% pen/
strep).
Tube formation assay
To induce thin-layer angiogenesis (TLA) two approaches
were taken: 1) Coverslip approach: 10 μl of basement matrix
(Geltrex™, Life Science Technologies) (kept continuouslyFigure 7 Confocal immunofluorescence of CD31 in HUVEC
differentiated in the TLA assay. Tube-like structures formed by
HUVEC in the presence of 25 ng/ml VEGF for 16 h at (A) x20, (B) x40
and (C) x63 magnification with CD31 labelled in red and nuclei in
blue. (D) represents secondary antibody control.on ice) was placed on the centre of a 13 mm glass cover-
slip and spread evenly with the use of a cell scraper, pro-
viding a thin layer covering the surface of the coverslip.
Each coverslip was subsequently transferred into the
well of a 24-well plate (pre-cooled on ice) with the use
of forceps. This process was repeated for each well before
the gel was allowed to set at 37°C for 30 minutes. 2) Direct
approach: 10 μl of basement matrix was placed directly
into the centre of each well of a 24-well plate and spread
evenly with the rubber end of a sterile 1 ml syringe in-
sert. The plate was placed at 37°C for 30 minutes to
allow the gel to set. After a 1 h serum-starvation in ex-
perimental media, cells were plated at a density of either
25,000 cells/cm2 (HUVEC) or 100,000 cells/cm2 (EA.
Hy926) [3] and incubated for either 16 hours (HUVEC)
[3] or 24 hours (EA.Hy926) in the appropriate experi-
mental medium supplemented with either 25 ng/ml
VEGF, 1 μM GW0742 or 0.01% DMSO vehicle control
(in duplicate). Phase-contrast images (4 images/well) were
acquired using a Leica DMIRB inverted microscope (×10
magnification) and the mean number of branches/high
powered field counted manually using imageJ software
to form each n-number from each donor. For clarity,
the structures routinely considered as branches for quanti-
fication purposes are highlighted in the accompanying
Additional file 7: Figure S1. For automated quantification,
images were analysed using the angiogenesis macro for
ImageJ.
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96-well plates, using wells coated with 2 μl/well of base-
ment matrix, spread evenly with the use of an insert of a
sterile Eppendorf 0.5 ml combitip (cat #: 0030089421).
HUVEC were seeded at a density of 25,000 cells/cm2 in
experimental medium supplemented with 25 ng/ml
VEGF, 100nM GW0742 or DMSO (vehicle) control (in
sextuplet), and incubated at 37°C/5% CO2 for 16 hours.
Phase-contrast images were acquired using a Leica DMIRB
microscope (×10 magnification) at the centre of each well
and the number of branches counted manually following
identification with ImageJ software.
For the comparison of the TLA assay with the trad-
itional assay approach, HUVEC (25,000 cells/cm2) were
seeded onto either 2 μl/well (TLA) or 50 μl/well (trad-
itional) of matrix in 96-well plates in the presence or
absence of VEGF (25 ng/ml) and left to form tubes for
16 hours. Images were acquired using the Leica DMIRB
inverted microscope as described above and average
number of branches/high power field quantified manu-
ally using ImageJ software. For live imaging of cell differ-
entiation, images were acquired every 30 minutes using
Leica SP5 confocal microscope (×10 objective).
Microscopy
HUVEC (25,000 cells/cm2) were seeded into a 35 mm
glass-bottom dish in which the glass area had been pre-
coated with 10 μl of Geltrex™ basement membrane and
cells induced to undergo tube formation with VEGF (25
ng/ml; 16 h). Medium was then replaced with fresh M199
containing 200nM MitoTraker green and the cells incu-
bated for a further 40 min at 37°C. Dye-containing medium
was then replaced with fresh M199 prior to imaging.
Differential interference contrast (DIC) images were
obtained using a Zeiss Axiovert 135 microscope fitted
with a ×20 objective. Confocal fluorescence images of
mitochondria were obtained using a Leica SP5 confocal
microscope fitted with a water emersion (×63) objective.
For z-stack series, images were obtained using a ×40 ob-
jective and 3D images constructed using Volocity soft-
ware (PerkinElmer; version 6.3.1).
Immunocytochemistry
The TLA assay was performed in 8-well chamber slides
(LabTek) with HUVEC (25,000 cells/cm2) seeded onto
3 μl of Geltrex basement matrix in the presence or ab-
sence of 25 ng/ml VEGF. Tube-like structures were
allowed to form for 16 h. After the careful removal of
media, cells were washed with PBS and then fixed with
4% PFA for 10 min. Cells were permeabilised with
0.1% Triton-x 100, blocked in 3% BSA 1% goat serum
for 30 min, and CD31 detected using anti-CD31 rabbit
polyclonal primary antibody (1:250; 1 h) (Santa Cruz)
and Alexa fluor 568 goat anti-rabbit secondary antibody(30 min; Life Technologies). Cells were then mounted
with DAPI-containing mounting media (Sigma, UK). Im-
ages were acquired with a Leica SP5 confocal fluores-
cence microscope. 3D images were constructed using
Volocity software (PerkinElmer; version 6.3.1).
RNA extraction and cDNA synthesis
Total RNA was extracted using the on-column Qiagen
(Manchester, UK) Total RNA Extraction kit as per the
manufacturer’s instructions. Briefly, media was removed
from the wells by careful pipetting and any dead cells
washed away with PBS. The plate was observed under a
bright-field microscope to check for any disruption of
cells. If no disruption was evident, 175 μl of lysis buffer
was added to each well and the resulting lysate was
pooled for each treatment to achieve a final volume of
350 μl of lysate per treatment. Lysates were put through
a genomic spin column to remove as much genomic DNA
contamination as possible. All remaining steps for RNA
purification was performed by strict adherence to the
manufacturer’s instructions. RNA was eluted into 40 μl of
nuclease-free H2O and concentrations were determined
using a NanoDrop-1000. cDNA was synthesised, as per
manufacturer’s guidelines using SuperScript™ II Reverse
Transcriptase obtained from Invitrogen. Briefly, isolated
RNA (equal amount per treatment) was combined with 1
μl of Oligo(dT) (500 μg/ml) and 1 μl dNTP mix (10 mM
each). The mixture was heated to 65°C for 5 minutes.
Subsequently, a master mix consisting of 5X first-strand
buffer, 0.1 M DTT and SuperScript™ II Reverse Transcript-
ase (100U/reaction) was added to the mixture to give a
final reaction volume of 20 μl. The mixture was then
heated to 42°C for 50 minutes before the reaction was
inactivated by heating to 72°C for 15 minutes. cDNA was
stored at −20°C until further analysis.
Quantitative RT-PCR
Quantitative RT-PCR was performed using Taqman
probe-based technology (Applied Biosystems) for cyclo-
oxygenase (COX)-2 (Cat # Hs01573477_g1) and the in-
ternal control gene GAPDH (Cat # Hs02758991_g1). For
each gene, a primer-probe master-mix and nuclease-free
H2O was prepared and pipetted into each well of a
96-well PCR plate (18 μl/well). 2 μl of cDNA sample was
then added to the appropriate wells. A minus cDNA
template (H2O) control was run for each gene. All reac-
tions were performed in duplicate. The PCR reaction was
run on a Chromo-4 machine using Opticon software
under the following conditions: 50°C for 2 min, 95°C for
10 min followed by 40 cycles of 95°C for 15 seconds and
60°C for 30 seconds with a plate read at the end of each
cycle. C(t) values were obtained at a cycle threshold value
of 0.1. Results were normalised to GAPDH and analysed
using the ΔΔCT method.
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All data are expressed as mean ± SEM. Statistical differ-
ences were assessed by paired Student’s t-test or repeated
measures one-way ANOVA with Dunnett’s post-analysis
where appropriate. p < 0.05 was considered statistically
significant.
Additional files
Additional file 1: Table S1. Common parameters measured in the
tube-formation assay as assessed by automated analysis software. Results
of the automated analysis macro for ImageJ of tube-like structures
formed by HUVEC seeded on to Geltrex-covered (10 μl) coverslips in
24-well plates in the presence of VEGF (25 ng/ml), GW0742 (1 μM) or
DMSO (0.01%) for 16 h. *p < 0.05 vs. control as determined by paired
Student’s t-test.
Additional file 2: Movie S1. Live monitoring of HUVEC dynamics when
plated on Geltrex basement matrix – TLA versus standard assay. HUVEC
dynamics over 16 h when plated on Geltrex basement matrix in either
the TLA assay (2 μl/well; A) or standard tube-formation assay (50 μl/well;
B) in 96-well plates stimulated to undergo tubulogenesis with 25 ng/ml
VEGF. Images were acquired using the Leica SP5 confocal microscope
(x10 objective).
Additional file 3: Movie S2. Live confocal imaging of mitochondria in
HUVEC tube-like structures from the TLA assay. Mitochondrial dynamics
over 10 min (green) in tubes formed by HUVEC induced to undergo
tubulogenesis by VEGF (25 ng/ml; 16 h). Images were obtained using
Leica SP5 confocal microscope (x40 objective).
Additional file 4: Movie S3. 3D imaging movie of mitochondria in
HUVEC tube-like structures from the TLA assay. 3D reconstruction of
tubes with visible mitochondria (green) formed by HUVEC induced to
undergo tubulogenesis by VEGF (25 ng/ml; 16 h).
Additional file 5: Movie S4. 3D imaging movie of CD31 (PECAM) in
HUVEC tube-like structures from the TLA assay. 3D reconstruction of
HUVEC stimulated to undergo tubulogenesis by VEGF (25 ng/ml)
showing positive expression of CD31 (red) at the cell membrane. Images
were acquired using Leica SP5 confocal microscope (x40 objective).
Additional file 6: Figure S2. RT-qPCR can be successfully performed on
RNA extracted directly from HUVEC undergoing tubulogenesis in the TLA
assay. Example of amplification plots demonstrating the successful
detection and amplification of glyceraldehyde phosphate dehydrogenase
(GAPDH) (A) and cyclooxygenase- 2 (COX-2) (B) by Taqman RT-qPCR and
associated C(t) values, n = 4 separate experiments.
Additional file 7: Figure S1. Manual quantification of tubes using
ImageJ software. Example of an original image of tube-like structures
formed by HUVEC in the presence of VEGF (25 ng/ml; 16 h) (A) and after
manual quantification using ImageJ (B) with Red markers highlighting
individual branches.
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